Pancreatic cancer is the seventh-leading cause of cancer death worldwide, and despite the increasing incidence of this disease, effective treatments are lacking and prognosis for patients with this tumor type remains poor, ...
May 16, 2023
0
13
A new clinical guideline from the American Society for Radiation Oncology (ASTRO) and European Society for Radiotherapy & Oncology (ESTRO) provides guidance on the use of definitive local therapy—including radiation and ...
Apr 25, 2023
0
15
Tisch Cancer Center scientists have developed unique models of the deadliest blood cancer, acute myeloid leukemia (AML), creating a transformative resource to study this cancer and eventually its drug response and drug resistance. ...
Apr 17, 2023
0
2
Patients with high-risk melanoma who received the immunotherapy drug pembrolizumab both before and after surgery to remove cancerous tissue had a significantly lower risk of their cancer recurring than similar patients who ...
Mar 1, 2023
0
12
Studying the mutations in kidney cancer after surgery could help to better predict the risk of the disease coming back, according to the latest results of a decade-long international study.
Feb 23, 2023
0
8
New data from a Yale Cancer Center-led clinical trial shows improved rates of survival and reduced risk of recurrence in patients taking osimertinib, a targeted therapy for non-small cell lung cancer (NSCLC). NSCLC is the ...
Jan 31, 2023
0
21
Older Black and Hispanic patients with advanced cancer are less likely than white patients to receive opioid medications for pain relief in the last weeks of life, according to a study led by investigators at Harvard-affiliated ...
Jan 18, 2023
0
10
A team led by researchers at NYU Langone Health's Perlmutter Cancer Center has identified a gene that drives development of the second most common type of lung carcinoma, offering greater insight into how the disease might ...
Jan 9, 2023
0
58
The European Society for Medical Oncology (ESMO) has developed a quality of life (QoL) checklist that is now integral to the ESMO-Magnitude of Clinical Benefit Scale (ESMO-MCBS)—a validated and reproducible tool to assess ...
Dec 20, 2022
0
4
Neuroblastoma is a tumor of the sympathetic nervous system that occurs mainly in young children. Every year, 25 children in the Netherlands receive this diagnosis. Surgery to remove the tumor tissue forms an important part ...
Dec 19, 2022
0
11
